← All organizations

National Institute of Cancerología

Academic/Hospital

Also known as: National Institute of Cancerología

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Apr 19, 2023

Timeline

No events for the selected filters.

Drugs by trial phase (6 distinct, 4 trials)

Phase 3 (2 own, 0 via acquisition)

Phase 2 (1 own, 0 via acquisition)

valganciclovir

Other trials (3 own, 0 via acquisition)

Indications

Studied for

Recent trials (8)

NCT06080841Lead sponsorN/AApr 19, 2023
NCT06156514Lead sponsorPhase 3Nov 6, 2019
NCT06156514Reponsible party - principal investigatorPhase 3Nov 6, 2019
NCT06156514Sponsor investigatorPhase 3Nov 6, 2019
NCT03994055Lead sponsorN/ANov 16, 2018
NCT03994055Study chairN/ANov 16, 2018
NCT03296553Reponsible party - principal investigatorPhase 2Oct 1, 2015
NCT03296553Lead sponsorPhase 2Oct 1, 2015

Details

Last known activity: Apr 19, 2023